JPH01124398A - Production of optically active hydantoins - Google Patents
Production of optically active hydantoinsInfo
- Publication number
- JPH01124398A JPH01124398A JP23025788A JP23025788A JPH01124398A JP H01124398 A JPH01124398 A JP H01124398A JP 23025788 A JP23025788 A JP 23025788A JP 23025788 A JP23025788 A JP 23025788A JP H01124398 A JPH01124398 A JP H01124398A
- Authority
- JP
- Japan
- Prior art keywords
- optically active
- carbamoyl
- amino acid
- formula
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001469 hydantoins Chemical class 0.000 title claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 244000005700 microbiome Species 0.000 claims abstract description 13
- 102000004190 Enzymes Human genes 0.000 claims abstract description 12
- 108090000790 Enzymes Proteins 0.000 claims abstract description 12
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229940091173 hydantoin Drugs 0.000 claims abstract description 11
- 125000003118 aryl group Chemical group 0.000 claims abstract description 7
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 5
- 230000002378 acidificating effect Effects 0.000 claims abstract description 4
- 241000187654 Nocardia Species 0.000 claims abstract description 3
- 125000000217 alkyl group Chemical group 0.000 claims abstract 2
- 235000008206 alpha-amino acids Nutrition 0.000 claims description 10
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims description 5
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 241000186216 Corynebacterium Species 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 241000589158 Agrobacterium Species 0.000 claims description 2
- ZWXPVQSPZVTEJE-UHFFFAOYSA-N 4-(carbamoylamino)-2,3-dihydrochromene-4-carboxylic acid Chemical class C1=CC=C2C(NC(=O)N)(C(O)=O)CCOC2=C1 ZWXPVQSPZVTEJE-UHFFFAOYSA-N 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 150000001923 cyclic compounds Chemical class 0.000 claims 1
- 125000005843 halogen group Chemical group 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 238000007363 ring formation reaction Methods 0.000 abstract description 8
- 150000001413 amino acids Chemical class 0.000 abstract description 7
- 230000003287 optical effect Effects 0.000 abstract description 5
- 230000000707 stereoselective effect Effects 0.000 abstract description 3
- 238000006911 enzymatic reaction Methods 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 53
- 238000000034 method Methods 0.000 description 25
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 23
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 239000013078 crystal Substances 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 239000000203 mixture Substances 0.000 description 18
- 239000007788 liquid Substances 0.000 description 16
- 230000001580 bacterial effect Effects 0.000 description 14
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 12
- 238000005119 centrifugation Methods 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 229910052783 alkali metal Inorganic materials 0.000 description 5
- -1 alkali metal cyanate salt Chemical class 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 150000001371 alpha-amino acids Chemical class 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- CJCSPKMFHVPWAR-JTQLQIEISA-N alpha-methyl-L-dopa Chemical compound OC(=O)[C@](N)(C)CC1=CC=C(O)C(O)=C1 CJCSPKMFHVPWAR-JTQLQIEISA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000013028 medium composition Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 229940035893 uracil Drugs 0.000 description 3
- BTKYMGDWHPJLPY-LBPRGKRZSA-N (2s)-3-(1,3-benzodioxol-5-yl)-2-(carbamoylamino)-2-methylpropanoic acid Chemical compound NC(=O)N[C@@](C(O)=O)(C)CC1=CC=C2OCOC2=C1 BTKYMGDWHPJLPY-LBPRGKRZSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 2
- 229910001863 barium hydroxide Inorganic materials 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- RRKTZKIUPZVBMF-IBTVXLQLSA-N brucine Chemical compound O([C@@H]1[C@H]([C@H]2C3)[C@@H]4N(C(C1)=O)C=1C=C(C(=CC=11)OC)OC)CC=C2CN2[C@@H]3[C@]41CC2 RRKTZKIUPZVBMF-IBTVXLQLSA-N 0.000 description 2
- RRKTZKIUPZVBMF-UHFFFAOYSA-N brucine Natural products C1=2C=C(OC)C(OC)=CC=2N(C(C2)=O)C3C(C4C5)C2OCC=C4CN2C5C31CC2 RRKTZKIUPZVBMF-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- MLIREBYILWEBDM-UHFFFAOYSA-N cyanoacetic acid Chemical compound OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000002024 ethyl acetate extract Substances 0.000 description 2
- LELOWRISYMNNSU-UHFFFAOYSA-N hydrogen cyanide Chemical compound N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000036647 reaction Effects 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- AQKADTOEOXISQG-JTQLQIEISA-N (2S)-2-(carbamoylamino)-2-phenylpropanoic acid Chemical compound C(N)(=O)N[C@@](C1=CC=CC=C1)(C(=O)O)C AQKADTOEOXISQG-JTQLQIEISA-N 0.000 description 1
- PLFOGGJHQOVQAF-NSHDSACASA-N (4s)-4-(carbamoylamino)-6-fluoro-2,3-dihydrochromene-4-carboxylic acid Chemical compound C1=C(F)C=C2[C@](NC(=O)N)(C(O)=O)CCOC2=C1 PLFOGGJHQOVQAF-NSHDSACASA-N 0.000 description 1
- PGCSVDXEADVLRG-QMMMGPOBSA-N (5s)-5-methyl-5-(2-methylpropyl)imidazolidine-2,4-dione Chemical compound CC(C)C[C@]1(C)NC(=O)NC1=O PGCSVDXEADVLRG-QMMMGPOBSA-N 0.000 description 1
- JNGWGQUYLVSFND-JTQLQIEISA-N (5s)-5-methyl-5-phenylimidazolidine-2,4-dione Chemical compound C=1C=CC=CC=1[C@]1(C)NC(=O)NC1=O JNGWGQUYLVSFND-JTQLQIEISA-N 0.000 description 1
- DBEYNBHRSXVDML-UHFFFAOYSA-N 4-(carbamoylamino)-6-fluoro-2-methyl-2,3-dihydrochromene-4-carboxylic acid Chemical compound FC1=CC=C2OC(C)CC(NC(N)=O)(C(O)=O)C2=C1 DBEYNBHRSXVDML-UHFFFAOYSA-N 0.000 description 1
- SBKRXUMXMKBCLD-UHFFFAOYSA-N 5-(2-methylsulfanylethyl)imidazolidine-2,4-dione Chemical compound CSCCC1NC(=O)NC1=O SBKRXUMXMKBCLD-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241001430228 Clavibacter sepedonicus Species 0.000 description 1
- 229940127463 Enzyme Inducers Drugs 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001509401 Gordonia rubripertincta Species 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000012295 chemical reaction liquid Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 150000002461 imidazolidines Chemical class 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 150000004658 ketimines Chemical class 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- CNFDGXZLMLFIJV-UHFFFAOYSA-L manganese(II) chloride tetrahydrate Chemical compound O.O.O.O.[Cl-].[Cl-].[Mn+2] CNFDGXZLMLFIJV-UHFFFAOYSA-L 0.000 description 1
- BHFLUDRTVIDDOR-UHFFFAOYSA-N methyl 2-amino-2-phenylacetate Chemical compound COC(=O)C(N)C1=CC=CC=C1 BHFLUDRTVIDDOR-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940001470 psychoactive drug Drugs 0.000 description 1
- 239000004089 psychotropic agent Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、ラセミ体のN−カルバモイル−α−アミノ酸
を立体選択的な酵素反応を利用して光学活性ヒダントイ
ン類に変換し光学分割する方法に関し、医薬などとして
有効な生理活性を示す光学活性化合物ないしはその合成
中間体を極めて有利に製造することを目的とする。[Detailed Description of the Invention] [Industrial Application Field] The present invention provides a method for converting racemic N-carbamoyl-α-amino acids into optically active hydantoins using a stereoselective enzymatic reaction and optically resolving them. The purpose of this invention is to very advantageously produce an optically active compound or a synthetic intermediate thereof that exhibits physiological activity that is effective as a medicine.
本発明の目的のひとつは、光学活性なヒダントイン類を
効率的に製造することにある。ヒダントイン類のなかに
は、抗けいれん剤あるいは向精神用薬などとして利用さ
れているものも多く、揮々の生理活性を示す化合物が知
られている。通常ラセミ体で用いられているが、分子内
に不斉炭素原子を有するヒダントイン類においては、一
般に特定の立体配置をもつもののみが生理活性に関与す
る場合が多く、薬効の向上あるいは副作用の減少といっ
た観点から光学活性体の使用が望まれる。One of the objects of the present invention is to efficiently produce optically active hydantoins. Among the hydantoins, many are used as anticonvulsants or psychotropic drugs, and compounds that exhibit remarkable physiological activity are known. Usually used in racemic form, among hydantoins with asymmetric carbon atoms in the molecule, only those with a specific steric configuration are often involved in physiological activity, improving drug efficacy or reducing side effects. From this point of view, it is desirable to use optically active substances.
従来、光学活性なヒダントイン類を製造する方法として
は、
1)光学活性なα−アミノ酸にシアン酸アルカリ金属塩
を反応させ、−旦、N−カルバモイル−α−アミノ酸と
した後、これを鉱酸中、加熱環化させてヒダントイン類
とする方法
2)光学活性シアノ酢酸をイソシアネートに誘導し、こ
れをアミンと反応しN−カルバモイルアミノニトリルを
得、最後に鉱酸中、加熱環化させてヒダントイン類とす
る方法
3)ラセミ体のヒダントイン類に光学活性ブルシンを加
え、ジアステレオマー塩を形成させ、浴媒に対する層解
度差を利用して光学分割する方法(J、Med、 Ch
em、 21 (12)、1294.4)ケトンに光学
活性アミンを反応させケチミンを得、これにシアン化水
素を不斉的に付加させた後、クロルスルホニルイソシア
ネートを反応させ光学活性ヒダントインとする方法(J
、 Org。Conventionally, methods for producing optically active hydantoins include: 1) Reacting an optically active α-amino acid with an alkali metal cyanate salt to form an N-carbamoyl α-amino acid, and then converting this into a mineral acid. 2) Optically active cyanoacetic acid is induced into isocyanate, which is reacted with an amine to obtain N-carbamoylaminonitrile, and finally heated and cyclized in mineral acid to form hydantoins. 3) A method of adding optically active brucine to racemic hydantoins to form diastereomeric salts, and performing optical resolution using the difference in phase solubility in bath media (J, Med, Ch
em, 21 (12), 1294.4) A method of reacting a ketone with an optically active amine to obtain ketimine, asymmetrically adding hydrogen cyanide to this, and then reacting it with chlorosulfonyl isocyanate to obtain an optically active hydantoin (J
, Org.
Chem、 47.4081.1982)などの方法が
知られている。Chem, 47.4081.1982) and other methods are known.
天然アミノ酸のように比較的容易に入手可能な光学活性
体を原料に使用できる場合は、1)の方法が有利である
が、そうでない場合ラセミ体を酸または塩基に誘導して
光学分割するなど、通常、原料を得るのに1)や2)の
方法は複雑な操作があらかじめ必要である。また、ラセ
ミ体のヒダントイン類を直接光学分割する3)の方法は
、分割剤に極めて強い毒性を有するブルシンを必要とす
ることから、その取り扱い及び製品中5のブルシンの混
入など操作性、安全性などの点で、工業的規模での生産
を目的とする場合、多くの問題が予想される。不斉合成
的に一挙に光学活性体を合成しようとする4)の方法に
おいては、腐価な光学活性アミンおヨヒクロルスルホニ
ルイソシアネートヲ当モル以と消費する丘、アミン由来
の不要な光学活性部位の除去が極めて困難であるなど、
実用上多くの難点を育している。If a relatively easily available optically active form such as a natural amino acid can be used as a raw material, method 1) is advantageous, but if not, the racemic form may be induced in an acid or base and optically resolved. Generally, methods 1) and 2) require complicated operations in advance to obtain the raw materials. In addition, method 3), in which racemic hydantoins are directly optically resolved, requires brucine, which has extremely high toxicity, as a resolving agent. For these reasons, many problems can be expected when producing on an industrial scale. In the method 4), which attempts to synthesize optically active substances at once by asymmetric synthesis, more than one mole of the corrosive optically active amine or chlorosulfonyl isocyanate is consumed, and unnecessary optically active sites derived from the amine are removed. It is extremely difficult to remove
It has many practical difficulties.
本発明者らは、ヒダントイン類あるいはα−アミノ酸か
ら容易に誘導できるN−カルバモイル−α−アミノ酸に
着目し、光学活性ヒダントイン類の効率的な合成法の開
発を目的に、生化学的な手法について鋭意検討を行なっ
た結果、微生物のなかにはN−カルバモイル−α−アミ
ノ酸を基質とし立体選択的な環上反応により光学活性な
ヒダントイン類を生成する能力を有する微生物が存在す
ることを見いだし、本反応が光学活性ヒダントインのみ
ならず光学活性アミノ酸類の製造法としても有効な、極
めて適用範囲の広い光学分割手段となり得ることを明ら
かにして本発明を完成した。The present inventors focused on hydantoins or N-carbamoyl-α-amino acids that can be easily derived from α-amino acids, and developed a biochemical method for the purpose of developing an efficient synthetic method for optically active hydantoins. As a result of extensive research, we discovered that there are microorganisms that have the ability to produce optically active hydantoins through a stereoselective cyclic reaction using N-carbamoyl-α-amino acids as substrates, and we believe that this reaction is capable of producing optically active hydantoins. The present invention was completed by revealing that the present invention can be used as an extremely wide-applicable optical resolution method that is effective as a method for producing not only optically active hydantoin but also optically active amino acids.
本発明の概略は次の式で表わされる。 The outline of the present invention is expressed by the following formula.
以下余白
NH= NH2
(VD (V)
すなわち、本発明は一般式(1)で示されるN−カルバ
モイル−a−アミノ酸(I)のラセミ体の一方の立体配
置のみを酵素的にヒダントイン類(It)に変換せしめ
たのち、未利用対掌体のN−カルバモイル−6−アミノ
酸01Dを分取し、酸性下に加熱環化反応することによ
り容易に立体配置を保持したまま光学活性ヒダントイン
類Gv)に化学的に変換することを目的とするものであ
る。本発明方法はラセミ体のN−カルバモイル−α−ア
ミノ酸を実質的に(■)と(IV)の光学活性ヒダント
イン類に光学分割する方法としても利用できる。更にま
た、本発明方法で得られる光学活性ヒダントイン類(1
)および対掌体N−カルバモイル−α−アミノ酸(9)
は、いずれもアルカリ加水分解して対応する光学活性a
−アミノ酸(VI、V月と変換できることから、本発明
方法はラセミ体のN−カルバモイル−a−アミノ酸を光
学活性α−アミノ酸に光学分割する方法としても利用で
きるなど広い適用性を有している。The following margin NH= NH2 (VD (V) That is, the present invention enzymatically converts only one configuration of the racemic N-carbamoyl-a-amino acid (I) represented by the general formula (1) into hydantoins (It ), the unutilized enantiomer N-carbamoyl-6-amino acid 01D is fractionated and subjected to a heating cyclization reaction under acidic conditions to easily form optically active hydantoins Gv) while maintaining the steric configuration. The purpose is to chemically convert it into The method of the present invention can also be used as a method for optically resolving racemic N-carbamoyl-α-amino acids into optically active hydantoins (■) and (IV). Furthermore, optically active hydantoins (1) obtained by the method of the present invention
) and the enantiomer N-carbamoyl-α-amino acid (9)
are all alkali hydrolyzed to give the corresponding optical activity a
- Amino acids (VI, V) can be converted, so the method of the present invention has wide applicability, such as being able to be used as a method for optically resolving racemic N-carbamoyl-a-amino acids into optically active α-amino acids. .
以下、本発明の詳細な説明する。The present invention will be explained in detail below.
本発明で原料として用いられるラセミ体のN−カルバモ
イル−α−アミノ酸は、ケトンを出発化合物として、α
−アミノ酸の一般的な合成法として周知のストレッカー
(5trecker )法またはブラフエラー(Buc
herer )法によって−Hα−アミノ酸を合成し、
これを更にシアン酸アルカリ金属塩と反応させることに
より容易に合成することができる。またブラフエラー法
の合成中間体であるヒダントイン類を、制御された条件
下に加水分解することにより直接N−カルバモイル−α
−アミノ酸を合成することも可能である。The racemic N-carbamoyl-α-amino acid used as a raw material in the present invention is produced using a ketone as a starting compound.
- The well-known Strecker method or Buc Error method is a general method for synthesizing amino acids.
-Hα-amino acid is synthesized by the herer) method,
It can be easily synthesized by further reacting this with an alkali metal cyanate. In addition, hydantoins, which are synthetic intermediates of the Bluff error method, can be directly synthesized by hydrolyzing N-carbamoyl-α under controlled conditions.
- It is also possible to synthesize amino acids.
本発明で使用する酵素は、通常微生物を培養することに
より得ることができるが、N−カルバモイル−α−アミ
ノ酸を立体選択的に環化して光学活性ヒダントイン類を
生成する能力を有するこれら微生物の分布は極めて広く
各種の種属にわたっている。例えば細菌に属するものと
しては、アエロバクタ−属(Aerobacter )
、アグロバクテリウム属(Agrobacterium
)、バシルス属(Bacillus )、コリネバク
テリウム属(Corynebacterium )、な
どがある。また放線菌に属するものとしてはノカルデイ
ア属(Nocardia )がある。The enzyme used in the present invention can usually be obtained by culturing microorganisms, and the distribution of these microorganisms has the ability to stereoselectively cyclize N-carbamoyl-α-amino acids to produce optically active hydantoins. is extremely wide and covers a wide variety of species and genera. For example, as a species belonging to bacteria, the genus Aerobacter
, Agrobacterium spp.
), Bacillus , Corynebacterium , and the like. Also, the genus Nocardia belongs to actinomycetes.
これら微生物の培養は通常液体栄養培地で行なわれる。Cultivation of these microorganisms is usually carried out in liquid nutrient media.
培地には、通常資化し得る炭素源、窒素源、各微生物の
生育に必須の無機塩栄養素を含有させるが、更に各種核
酸塩基およびそれらの誘導体その他の酵素誘導剤を少量
添加して、必要な酵素を適応的に増強させることが望ま
しい。培養時の温度は20〜70”C,pHは4〜10
の範囲が用いられる。通気撹拌により微生物の生育を促
進することもできる。The culture medium usually contains assimilated carbon sources, nitrogen sources, and inorganic salt nutrients essential for the growth of each microorganism, but it also contains small amounts of various nucleobases, their derivatives, and other enzyme inducers. It is desirable to adaptively enhance enzymes. The temperature during culturing is 20 to 70"C, and the pH is 4 to 10.
range is used. The growth of microorganisms can also be promoted by aeration and stirring.
N−カルバモイル−α−アミノ酸のヒダントイン類への
環化反応においては、前記のようにして得た微生物の培
養液、菌体または菌体処理物などを酵素として使用する
ことができる。微生物の培養液をそのまま用いることも
できるが、更に望ましくは培養液から分離した菌体を使
用する。菌体は、生菌体のままで用い得ることは勿論で
あるが、貯蔵および取扱いの便宜から凍結乾燥菌体のよ
うな乾燥菌体として用いることもできる。更に、菌体磨
砕物または菌体抽出物を微生物酵素として本反応に利用
することができる。In the cyclization reaction of N-carbamoyl-α-amino acids to hydantoins, the culture solution, bacterial cells, or treated microbial cells of the microorganisms obtained as described above can be used as the enzyme. Although the culture solution of the microorganism can be used as it is, it is more preferable to use microbial cells separated from the culture solution. The cells can of course be used as live cells, but for convenience of storage and handling, they can also be used as dried cells such as freeze-dried cells. Furthermore, a bacterial cell grind product or a bacterial cell extract can be used as a microbial enzyme in this reaction.
反応基質であるN−カルバモイル−α−アミノ酸の反応
液中での濃度は、01%から50%程度の高濃度まで用
いることができる。好ましい反応pHとしては5〜8の
範囲が用いられる。pHが5未満では酵素が失活しやす
<、pH8をこえるとヒダントイン類の溶解度が増加し
て反応が完結しにくくなるので実用性に乏しい。最適p
Hは、反応基質および使用酵素によって異なるが、おお
むねpH5〜8の範囲に含まれている。環化反応の進行
に伴ってpHは次第にアルカリ側に移行するので、適時
中和剤を添加して最適pHに保持することが望ましい。The concentration of the reaction substrate N-carbamoyl-α-amino acid in the reaction solution can range from 0.1% to as high as 50%. A preferable reaction pH range is from 5 to 8. If the pH is less than 5, the enzyme is easily inactivated, and if the pH exceeds 8, the solubility of hydantoins increases, making it difficult to complete the reaction, making it impractical. optimal p
The pH of H varies depending on the reaction substrate and the enzyme used, but is generally within the pH range of 5 to 8. Since the pH gradually shifts to the alkaline side as the cyclization reaction progresses, it is desirable to maintain the optimum pH by adding a neutralizing agent from time to time.
中和剤としては、塩酸、硫酸など鉱酸が適当である。本
反応に際しての反応温度は、通常30〜60°Cの範囲
が用いられるが、使用する酵素に適した温度が採用され
る。これら反応条件ならびに酵素量を選択することによ
り、はぼ定量的な変換率を得ることは比較的容易であり
、未反応N−カルバモイル−α−アミノ酸も極めて高い
光学純度を有する対掌体として単離することが可能であ
る。As the neutralizing agent, mineral acids such as hydrochloric acid and sulfuric acid are suitable. The reaction temperature for this reaction is usually in the range of 30 to 60°C, but a temperature suitable for the enzyme used is employed. By selecting these reaction conditions and enzyme amounts, it is relatively easy to obtain a quantitative conversion rate, and even unreacted N-carbamoyl-α-amino acid can be converted into a single enantiomer with extremely high optical purity. It is possible to separate.
この酵素的環化反応によって生成した光学活性ヒダント
イン類および未利用対掌体N−カルパモイノC−α−ア
ミノ酸を単離するには、公知の方法が採用できる。一般
に本発明方法で生成するようなα−炭素原子に水素原子
を含まないヒダントイン類は、pH8ないし9以下では
水性媒体に対して極めて難溶性であるため、環化反応の
進行に伴って生成するヒダントイン類は通常はとんど大
部分が結晶として析出した状態となる。ところがpH1
1以上ではこれらヒダントイン類はアルカリ金属塩とな
って易溶性を示す。一方、反応基質であるN−カルバモ
イル−α−アミノ酸は、本反応条件(pH5〜8)では
アルカリ金属塩となり、極めて大きな溶解度を示し、完
全に溶解した状態となるが、pH4以下ではカルボキシ
ル基が遊離の状態となり極端な不溶性を示す。このよう
なヒダントイン類およびN−カルバモイル−α−アミノ
酸の水性媒体中でのpHに対する溶解度の変化。Known methods can be used to isolate the optically active hydantoins and the unused enantiomer N-carpamoino C-α-amino acid produced by this enzymatic cyclization reaction. In general, hydantoins that do not contain a hydrogen atom on the α-carbon atom, such as those produced by the method of the present invention, are extremely poorly soluble in aqueous media at pH 8 to 9 or below, and therefore are produced as the cyclization reaction progresses. Most of the hydantoins are usually precipitated as crystals. However, pH 1
When the amount is 1 or more, these hydantoins become alkali metal salts and exhibit easy solubility. On the other hand, the reaction substrate, N-carbamoyl-α-amino acid, becomes an alkali metal salt under the present reaction conditions (pH 5 to 8), exhibits extremely high solubility, and becomes completely dissolved, but at pH 4 or lower, the carboxyl group is It becomes a free state and shows extreme insolubility. Changes in the solubility of such hydantoins and N-carbamoyl-α-amino acids with respect to pH in an aqueous medium.
を利用して、極めて容易に生成ヒダントイン類と未利用
対掌体N−カルバモイル−α−アミノ酸を分別、単離す
ることも可能である。勿論、酢酸エチルの如き有機溶剤
への高い溶解度を利用した抽出方法によっても容易に分
別、単離することができる。It is also possible to very easily separate and isolate the produced hydantoins and the unutilized enantiomer N-carbamoyl-α-amino acid using this method. Of course, it can also be easily separated and isolated by an extraction method that takes advantage of its high solubility in organic solvents such as ethyl acetate.
未利用対掌体N−カルバモイル−α−アミノ酸は、塩酸
または硫酸のような鉱酸酸性下、あるいは酢酸のような
有機酸中で70〜100°Cに加熱撹拌するといった公
知の方法を採用することにより、容易に化学的に環化し
て光学活性ヒダントイン類に変換することも可能である
。また、苛性ソーダ、苛性カリ、水酸化バリウムのよう
なアルカリ金属塩を用いて加水分解するか、あるいは鉱
酸酸性下に当量の亜硝酸ソーダなどを用いてカルバモイ
ル基を酸化するなどの方法によって、このN−カルバモ
イルーα−アミノ酸を光学活性a−アミノ酸に変換する
ことも可能である。The unused enantiomer N-carbamoyl-α-amino acid is prepared by a known method such as heating and stirring at 70 to 100°C under mineral acid acidity such as hydrochloric acid or sulfuric acid, or in an organic acid such as acetic acid. By doing so, it is also possible to easily chemically cyclize and convert into optically active hydantoins. In addition, the carbamoyl group can be oxidized by hydrolysis using an alkali metal salt such as caustic soda, caustic potash, or barium hydroxide, or by oxidizing the carbamoyl group using an equivalent amount of sodium nitrite under acidic mineral acid. -Carbamoyl- It is also possible to convert α-amino acids into optically active α-amino acids.
また、本発明により必然的に副生ずる、目的としない対
掌体は、アルカリ加水分解などを通じて、−旦α−アミ
ノ酸とした後、これを次亜ハロゲン化水素酸などの酸化
剤を用いる公知の方法によりケトンとして回収し、これ
を新たなラセミ体のN−カルバミル−α−アミノ酸とな
して循環再利用する′ことにより、本発明の効率を一層
高め得ることは云うま、でもない。In addition, undesired enantiomers, which are inevitably produced as a by-product of the present invention, can be obtained by using known methods such as alkaline hydrolysis, etc., to convert the α-amino acid into an α-amino acid, and then using an oxidizing agent such as hypohalous acid. It goes without saying that the efficiency of the present invention can be further improved by recovering the ketone by a method and recycling it as a new racemic N-carbamyl-α-amino acid.
以下に、実施例を記載して本発明を説明する。 The present invention will be explained below with reference to examples.
実施例1
下記の組成からなる栄養液体培地を調製し、綿栓をした
50ON/容肩付フラスコに100m1ずつ分注後、1
20“Cで20分間蒸気殺菌を行なった。Example 1 A nutrient liquid medium having the following composition was prepared, and after dispensing 100ml each into a 50ON/capacity flask with a cotton stopper, 1
Steam sterilization was performed at 20"C for 20 minutes.
培地組成:
肉エキス 0.5%(重量%)酵母エキス
0.5%
ポリペプトン 1.0%
NaCl 0.15%
ウラシル 010%
MnCl2−4H2020ppm
(pH7,0)
予め、ブイヨン寒天スラントで30°C124時間培養
した表−1に示す微生物を上記栄養培体培地に一白金耳
接種して33°Cで24時間振とう下に培養を行なった
。これらの培養液の40罰を用い、遠心分離して得た生
菌体を更に同量の0.9%食塩水で洗浄したのち、再び
遠心分離して集菌し、同食塩水で10m1の液量とした
菌体懸濁液を調製して下記反応成分に使用した。Medium composition: Meat extract 0.5% (wt%) yeast extract
0.5% Polypeptone 1.0% NaCl 0.15% Uracil 010% MnCl2-4H 2020 ppm (pH 7,0) The microorganisms shown in Table 1, which had been previously cultured on a bouillon agar slant at 30°C for 124 hours, were added to the above nutrient medium. One platinum loopful was inoculated and cultured at 33°C for 24 hours with shaking. Using 40 volumes of these culture solutions, the viable cells obtained by centrifugation were further washed with the same amount of 0.9% saline, centrifuged again to collect bacteria, and diluted with 10ml of the same saline. A bacterial cell suspension was prepared and used as the reaction component described below.
反応液組成
(1) (1)−N−カルバモイル−α−フエリルグ
リシンまたは(几5)−4−カルバモイルアミノ−6−
フルオロクロマン−4−カルボン酸の250 tt m
oleを0.1M−リン酸緩衝液に溶解しくpH7,2
)、液量2.5 ytlに調整した基質層液
(2)前記菌体懸濁液 2.5 ml上記(1
)と(2)を共栓付小型試験管に入れ、磁気回転子を用
いスターラーで撹拌しなから57°Cにて48時間反応
させた。なお対照として基質溶液(1)に生菌体を加え
ないものを同様に反応条件下においた。反応後、反応液
の一部をサンプリングし、萬速液体クロマトグラフィー
により反応系に生成した4−メチル−4−フェニル−イ
ミダゾリジン−2,5’−ジオンまたは6−フルオロ−
スピロ−〔クロマン−4,4′−イミダゾリジン) −
2’、 s’−ジオン量を定量した。Reaction solution composition (1) (1)-N-carbamoyl-α-ferrylglycine or (几5)-4-carbamoylamino-6-
250 tt m of fluorochroman-4-carboxylic acid
Dissolve ole in 0.1M phosphate buffer at pH 7.2.
), substrate layer solution adjusted to a liquid volume of 2.5 ytl (2) 2.5 ml of the above bacterial cell suspension (1
) and (2) were placed in a small test tube with a stopper and allowed to react at 57°C for 48 hours while stirring with a stirrer using a magnetic rotor. As a control, a substrate solution (1) without viable cells was placed under the same reaction conditions. After the reaction, a part of the reaction solution was sampled and 4-methyl-4-phenyl-imidazolidine-2,5'-dione or 6-fluoro-dione produced in the reaction system was analyzed by rapid liquid chromatography.
Spiro-[chroman-4,4'-imidazolidine) -
The amount of 2', s'-dione was quantified.
測定条件:カラム; Finepak S I L 0
n(4,6朋IDX250wz)日本分光■製、移動相
; 60 mMリン酸緩衝液(p I−I 2.5 )
/MeOH=83717 (V/V)、流速; 2.
O肩l/min 。Measurement conditions: Column; Finepak S I L 0
n (4,6 IDX250wz) manufactured by JASCO ■, mobile phase; 60 mM phosphate buffer (p I-I 2.5)
/MeOH=83717 (V/V), flow rate; 2.
O shoulder l/min.
検出:210nm、内部標準;4−(2−メチルチオエ
チル)イミダゾリジン−2,5−ジオン各微生物につい
て夫々測定した結果は表−1に示す通りであった。Detection: 210 nm, internal standard: 4-(2-methylthioethyl)imidazolidine-2,5-dione The results of measurements for each microorganism are shown in Table 1.
以下余白
生成したイミダゾリジン誘導体はいずれもイミダゾリジ
ン4位の炭素に関してR体の光学活性体であった。All of the imidazolidine derivatives produced below were optically active forms of the R form with respect to the carbon at the 4-position of the imidazolidine.
実施例2
下記の組成からなる栄養液体培地を調製し、綿栓をした
500#I/容肩付振盪フラスコに150y?ずつ分注
して120℃、20分間蒸気殺菌を行なつtこ。Example 2 A nutrient liquid medium having the following composition was prepared and placed in a 500#I shoulder shake flask with a cotton stopper for 150y. Dispense in portions and steam sterilize at 120°C for 20 minutes.
培地組成:
肉エキス 2.0%(w/v%)グルコース
0.8%
NaCl 0.3%
ウラシル 0.1%
pH7,5
予め、ブイヨン寒天スラントで33°C,20時間培養
したパシルス・スピーシーズ(Eucillusspe
cies ) KNK 108 (微工研条寄第88
7号(FERM BP−887))を上記栄養液体培
地に一白金耳接種して、33°Cで22時間振とう下に
培養を行なった。Medium composition: Meat extract 2.0% (w/v%) Glucose 0.8% NaCl 0.3% Uracil 0.1% pH 7.5 Pacillus sp. cultured in advance at 33°C in bouillon agar slant for 20 hours. (Eucillus sp.
cies) KNK 108 (Feikoken Joyori No. 88
No. 7 (FERM BP-887)) was inoculated into the above-mentioned nutrient liquid medium, and cultured under shaking at 33°C for 22 hours.
この培養液の200 mlを用い、遠心分離して得た生
菌体を更に同量の09%食塩水で洗浄したのち、再び遠
心分離して集菌し、下記の反応液成分として使用した。Using 200 ml of this culture solution, the viable cells obtained by centrifugation were further washed with the same amount of 09% saline, and then centrifuged again to collect the bacteria and used as a component of the reaction solution described below.
反応液組成:
(1) (Its)−4−カルバモイルアミノ−6−
フルオロクロマン−4−カルボン酸1.20 fをナト
リウム塩として溶解させ(pH7,2)、液量20m1
に調整した基質溶液
(2)前記培養[20(lyeより集菌した生菌体を
。Reaction liquid composition: (1) (Its)-4-carbamoylamino-6-
Dissolve 1.20 f of fluorochroman-4-carboxylic acid as a sodium salt (pH 7.2) in a liquid volume of 20 ml.
Substrate solution adjusted to (2) The above culture [20 (live bacteria collected from lye
.
0.9%食塩水を用いて懸濁し、液量20slに調整し
た菌体懸濁液
上記(1)、(2)を混合して100肩l容四ツロ丸底
フラスコに入れ、撹拌しながら37℃にて48時間反応
した。この反応中、0.5 N−H(:!1溶液を用い
て反応系のpHを7.2に継続的に保持した。反応後、
反応液を冷却しpHを7.0に調整した後、遠心分離に
より反応中に析出した結晶と菌体の不溶混合物とと澄液
とに分離した。このようにして得た不溶混合物を5(1
+/の水に懸濁した後、酢酸工チ)し1001111を
用い2回抽出操作を行ない酢酸エチル抽出液を得た。こ
の抽出液より減圧上酢酸エチルを留去して得た残渣をエ
タノールより再結晶して白色結晶0.51gを得た。Suspend the bacterial cell suspension using 0.9% saline and adjust the liquid volume to 20 sl. Mix the above (1) and (2) and put it in a 100-l capacity four-sided round bottom flask, while stirring. The reaction was carried out at 37°C for 48 hours. During this reaction, the pH of the reaction system was continuously maintained at 7.2 using a 0.5 N-H (:!1 solution. After the reaction,
After the reaction solution was cooled and the pH was adjusted to 7.0, it was separated by centrifugation into an insoluble mixture of crystals and bacterial cells precipitated during the reaction and a clear solution. The insoluble mixture thus obtained was
After suspending in +/ water, acetic acid was added and extraction was performed twice using 1001111 to obtain an ethyl acetate extract. Ethyl acetate was distilled off from this extract under reduced pressure, and the resulting residue was recrystallized from ethanol to obtain 0.51 g of white crystals.
分析の結果本化合物を@)−6−フルオロ−スピロ−〔
クロマン−4,4′−イミダゾリジン〕−z: 5’−
ジオンと同定した。As a result of analysis, this compound was found to be @)-6-fluoro-spiro-[
Chroman-4,4'-imidazolidine]-z: 5'-
It was identified as Zeon.
NMRδppm (DMF−d1ン :2.1〜2.6
(2H,m、CH2)、4.1〜4.8 (2H,m、
CH2)、6.8〜7.2 (3H,m、 arom
atic)、8.4(IH。NMRδppm (DMF-d1: 2.1 to 2.6
(2H, m, CH2), 4.1-4.8 (2H, m,
CH2), 6.8-7.2 (3H, m, arom
atic), 8.4 (IH.
s、NH)、1.0 (IH,br s、 NH)I
Rcm (KBr−disk) : 3340゜32
05.1760.17M0,1490゜1400.12
60.1160
(α’l 25−−5 5.0° (cm 1.0
、 MeOH)mp、 241〜242°C
一方、と澄液のpHを6N−H(:!l溶液を用い、1
0に調整すると白色沈澱が析出した。この沈澱を戸数し
、エタノールより再結晶して白色結晶054gを得た。s, NH), 1.0 (IH, br s, NH)I
Rcm (KBr-disk): 3340°32
05.1760.17M0,1490°1400.12
60.1160 (α'l 25--5 5.0° (cm 1.0
, MeOH)mp, 241-242°C On the other hand, the pH of the clear solution was adjusted to 1 using a 6N-H(:!l solution).
When adjusted to 0, a white precipitate was deposited. This precipitate was separated and recrystallized from ethanol to obtain 054 g of white crystals.
分析の結果、本化合物を(S)−4−カルバモイルアミ
ノ−6−フルオロクロマン−4−カルボン酸と同定した
。As a result of the analysis, this compound was identified as (S)-4-carbamoylamino-6-fluorochroman-4-carboxylic acid.
NMRδppm CDMSO−ds) : 2.3〜2
.7(2H,m、 CH2)、 3.9〜4.5 (2
H,m、 CH2)、5.7 (2H,s、Na2)、
6.7 (IH,S、M)、6.8〜7.4 (3H,
m、 aromatic)■几 art (KEr−
disk ) : 3470 。NMRδppm CDMSO-ds): 2.3-2
.. 7 (2H, m, CH2), 3.9~4.5 (2
H, m, CH2), 5.7 (2H, s, Na2),
6.7 (IH, S, M), 6.8-7.4 (3H,
m, aromatic) ■几 art (KEr-
disk): 3470.
3380.1720,1640.1560゜1500.
1485,1425.1370゜(/2) o=+11
2.7° (c = 0.5 、 MeOH)mp、
196〜l 97”C
実施例3
実施IM2で得た(S)−力ルバモイルアミノ−6−フ
ルオロクロマン−4−カルボン酸400〜を2 N−H
Cl 10 yxlに懸濁し、マグネチックスクーラー
で撹拌しながら80℃にて3.5時間反応した。3380.1720, 1640.1560°1500.
1485,1425.1370゜(/2) o=+11
2.7° (c = 0.5, MeOH) mp,
196~l 97''C Example 3 (S)-Rubamoylamino-6-fluorochroman-4-carboxylic acid 400~ obtained in Example IM2 was converted into 2N-H
It was suspended in Cl 10 yxl and reacted at 80° C. for 3.5 hours while stirring with a magnetic cooler.
反応後、冷蔵庫に一夜放置し、析出結晶を戸数し、減圧
下60°Cにて乾燥し、白色結晶340〜を得た。After the reaction, the mixture was left in a refrigerator overnight, and the precipitated crystals were collected and dried at 60°C under reduced pressure to obtain white crystals with a temperature of 340°C.
本化合物は分析の結果、(S)−6−フルオロ−スピロ
−〔クロマン−4,4′−イミダゾリジン〕−2: s
’−ジオンの標品と完全に一致した。As a result of analysis, this compound was found to be (S)-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2: s
'-Dione was completely consistent with the standard sample.
(/Z)’、;−+ 55.7° (cm1.0. M
eOH)mp、 24’1.5〜242.5℃実施例
4
実施例2と同様にして得たバシルス・ス5ビーシーズ(
Bacillus 5pecies)KNK 10 g
(微工研条寄第887号(FERM BP−887
))の培養液5QOrttlに(RSンーN−カルバモ
イル−α−メチル−3,4−メチレンジオキシフェニル
アラニンを15.OF加え1ON−NaOH溶液でpH
72に調整し、37°Cにて48時間反応した。この反
応中、0.5N−HCI溶液を用いて反応系のp I−
Iを7.2に継続的に保持した。反応後、反応液を冷却
しpHを70に調整した後、遠心分離により反応中に析
出した結晶と菌体の不浴混合物と上澄液とに分離した。(/Z)',;-+ 55.7° (cm1.0.M
eOH) mp, 24'1.5-242.5°C Example 4 Bacillus 5 B seeds obtained in the same manner as in Example 2 (
Bacillus 5pecies) KNK 10 g
(FERM BP-887 No. 887)
Add 15.0F of (RS-N-N-carbamoyl-α-methyl-3,4-methylenedioxyphenylalanine) to the culture solution 5QOrttl of )) and adjust the pH with 1ON-NaOH solution.
72 and reacted at 37°C for 48 hours. During this reaction, a 0.5N HCI solution was used to adjust the p I-
I was held continuously at 7.2. After the reaction, the reaction solution was cooled and the pH was adjusted to 70, and then separated by centrifugation into an unbathed mixture of crystals precipitated during the reaction and bacterial cells, and a supernatant.
このようにして得たと澄液のpHを6N−I(C1溶液
を用い1.0に調整すると白色沈澱が析出した。この沈
澱を濾取し充分水洗した後、減圧下に乾燥しくS) −
N−カルバモイル−α−メチル−3,4−メチレンジオ
キシフェニルアラニンの白色結晶7.31を得た。When the pH of the thus obtained clear liquid was adjusted to 6N-I (1.0 using C1 solution, a white precipitate was deposited. This precipitate was collected by filtration, thoroughly washed with water, and then dried under reduced pressure.) -
7.31 of white crystals of N-carbamoyl-α-methyl-3,4-methylenedioxyphenylalanine were obtained.
NMRδppm CDM S O−da ) : 1.
3(3H。NMRδppm CDMSO-da): 1.
3 (3H.
S、Q−CH3)、2.9〜5.3 (2H,m、 α
−CH2)、5、6 (2H,s 、 NFI2 )、
5.9 (2H,s、 CH2)、7、0 (IH,s
、 NH)、6.4〜18 (3H,m。S, Q-CH3), 2.9-5.3 (2H, m, α
-CH2), 5,6 (2H,s, NFI2),
5.9 (2H,s, CH2), 7,0 (IH,s
, NH), 6.4-18 (3H, m.
aromatic )
IRcyt (KBr−disk) : 3500゜
3400.3330.2$00,1695゜1600.
1570.1490.1440゜1390.1280.
1245
〔α片=+92.0°(cm0.5.0.INlN−N
a0H)、190〜192℃
一方、遠心分離して得た不溶物に水1000m?を加え
、l0N−NaOH溶液によりpHを11.5に調整し
、1時間撹拌して混在結晶を溶解させた後、再び遠心分
離して菌体を除去した。次いで6N−HC1溶液を用い
、この上澄液のpHを7.0に再調整すると白色沈澱が
析出した。この沈澱を戸数し、エタノールより再結晶し
て@)−4’−メチル−4’−(3,4−メチレンジオ
キシフェニルメチル)−イミダゾリジン−2: s’−
ジオンの白色結晶6.71を得た。aromatic) IRcyt (KBr-disk): 3500°3400.3330.2$00, 1695°1600.
1570.1490.1440゜1390.1280.
1245 [α piece = +92.0° (cm0.5.0.INlN-N
a0H), 190-192°C On the other hand, the insoluble matter obtained by centrifugation was heated with water at 1000 m? was added, the pH was adjusted to 11.5 with a 10N-NaOH solution, the mixture was stirred for 1 hour to dissolve mixed crystals, and then centrifuged again to remove the bacterial cells. Then, the pH of this supernatant liquid was readjusted to 7.0 using 6N-HC1 solution, and a white precipitate was deposited. This precipitate was separated and recrystallized from ethanol to give 2)-4'-methyl-4'-(3,4-methylenedioxyphenylmethyl)-imidazolidine-2: s'-
6.71 of white crystals of dione were obtained.
NMII δppm (DM S O−ds ) :
1.5 (3H。NMII δppm (DMSO-ds):
1.5 (3H.
s、a−CBr4)、2.8 (2f(、q、 /2−
CHt )、5.9(2I−1,s、CH2)、 6.
5〜6.8 (3FI、 m。s, a-CBr4), 2.8 (2f(, q, /2-
CHt), 5.9 (2I-1,s, CH2), 6.
5-6.8 (3FI, m.
aromatic )、 7.9 (IH,s、NH
)、 10.3(IH,s、N1−I)
IRCm (KBr−disk): 3 34
0゜3190、 3070. 2895. 1760゜
1710、 1505. 1490. +440゜1
405、 1300. 1280. 1245(/Z’
l 25= +63.6°(c =0.5. 0.lN
−Na0H)mp、 22.6〜229°C
実施例5
下記の組成からなる栄養液体培地を調製し、綿栓をした
50(1+7容肩付振盪フラスコに100mtずつ分注
し、120“Cで20分間蒸気殺菌を行なった。aromatic), 7.9 (IH, s, NH
), 10.3 (IH, s, N1-I) IRCm (KBr-disk): 3 34
0°3190, 3070. 2895. 1760°1710, 1505. 1490. +440°1
405, 1300. 1280. 1245(/Z'
l 25 = +63.6° (c = 0.5. 0.lN
-Na0H)mp, 22.6-229°C Example 5 A nutrient liquid medium with the following composition was prepared and dispensed in 100 ml portions into 50 (1+7 capacity shoulder shake flasks) with cotton plugs, and incubated at 120"C. Steam sterilization was performed for 20 minutes.
培地組成:
肉エキス 0.5%(w/v%)酵母エキス
0.5%
ポリペプトン 1.0%
NaC10,3%
ウラシル 01%
塩化マンガン・4水和物 20 ppmpI−I 7
.0
予め、ブイヨン寒天スラントで33°C124時間培養
したコリネバクテリウム・セペドニカム(Ooryne
bacterium sepedonicum ) I
F 013259を上記栄養液体培地に一白金耳接種
して、33°Cで24時間振とう下に培養を行なった。Medium composition: Meat extract 0.5% (w/v%) Yeast extract 0.5% Polypeptone 1.0% NaC 10.3% Uracil 01% Manganese chloride tetrahydrate 20 ppmp I-I 7
.. 0 Corynebacterium cepedonicum (Ooryne
bacterium sepedonicum ) I
A loopful of F 013259 was inoculated into the above nutrient liquid medium, and cultured at 33°C for 24 hours with shaking.
この培養液の200m/を用い、遠心分離して得た生菌
体を更に同量の0.9%食塩水で洗浄したのち、再び遠
心分離して集菌し、下記の反応液成分として使用した。Using 200m/ml of this culture solution, the viable cells obtained by centrifugation were further washed with the same amount of 0.9% saline, centrifuged again to collect the bacteria, and used as a component of the reaction solution below. did.
反応液組成:
(D (R8)−N−カルバモイル−α−メチルロイ
シン2.4Ofをナトリウム塩として溶解させ(−pl
l 7.2 )、液量40tttlに調整した基質溶液
(2) H肥培養液200耐より集菌した生菌体を、
09%食塩水を用いて懸濁し、液量40ystに調整し
た菌体懸濁液
上記(1)、(2)を混合して200m1容四ツロ丸底
フラスコに入れ、撹拌しなから37°Cにて20時間゛
反応させた。この反応中、0.5 N−H0I溶液
を用いて反応系のpHを7.2に継続的に保持した。反
応後、反応液を遠心分離して菌体を除去した。得られた
上澄液のpHを7.0に再調整して、酢酸エチル100
M/で2回抽出を行ない、抽出液の酢酸エチルを減圧上
留去して@)−4−メチル−4−イソブチルイミダゾリ
ジン−2,5−ジオンを白色結晶として10.42y得
た。Reaction solution composition: (D (R8)-N-carbamoyl-α-methylleucine 2.4Of was dissolved as a sodium salt (-pl
17.2), substrate solution (2) adjusted to a liquid volume of 40 tttl Live bacteria collected from H fertilizer culture solution 200 t.
0.09% saline solution and adjusted the liquid volume to 40yst. Mix (1) and (2) above, put into a 200ml four-bottle round bottom flask, and heat at 37°C without stirring. The reaction was carried out for 20 hours. During this reaction, the pH of the reaction system was continuously maintained at 7.2 using a 0.5 N-H0I solution. After the reaction, the reaction solution was centrifuged to remove bacterial cells. The pH of the obtained supernatant was readjusted to 7.0, and 100% of ethyl acetate was added.
Extraction was performed twice with M/, and ethyl acetate in the extract was distilled off under reduced pressure to obtain 10.42 y of white crystals of -4-methyl-4-isobutylimidazolidine-2,5-dione.
NM几 δppm (DMSO−de) : 1.8
(6H。NM⇠ δppm (DMSO-de): 1.8
(6H.
t、CHs)、1.3 (5H,s、 a−CH3)、
1.4〜L 8 (5H,m、 CH2CH2)、乙9
(I H+ s。t, CHs), 1.3 (5H, s, a-CH3),
1.4~L 8 (5H, m, CH2CH2), Otsu 9
(I H+s.
NH)、 10.6 (IH,s、 NH)丁R,cm
(K]3r−disk) : 3200 。NH), 10.6 (IH, s, NH) R, cm
(K]3r-disk): 3200.
3050.2950,1760,1705゜1570、
1430. 1370. 1280゜1230、 1
200
(α)25=+ 0.8°(cm0.5 、0. I
N−Na0H)mp、 131〜134°C
酢酸エチル抽出した水層のpHを1.0に調整した後、
再度酢酸エチル100rttlで2回抽出を行ない、抽
出液の酢酸エチルを減圧上留去して、(S)−N=カル
バモイル−a−メチルロイシン1.10 !7を白色結
晶として得た〔〔α’)25=+8.0°(cm0.5
゜O,I N−NaOH) )。こうして得た(S)
−N−カルバモイル−α−メチルロイシン1.001を
2N−HC1溶液25m1に加え80°Cにて2時間加
熱環化して、(S)−4−メチル−4−イソブチルイミ
ダゾリジン−2,5−ジオン0.851を白色結晶とし
て得た。3050.2950,1760,1705°1570,
1430. 1370. 1280°1230, 1
200 (α)25=+0.8° (cm0.5, 0.I
N-NaOH)mp, 131-134°C After adjusting the pH of the aqueous layer extracted with ethyl acetate to 1.0,
Extraction was performed again twice with 100 rttl of ethyl acetate, and the ethyl acetate in the extract was distilled off under reduced pressure to yield (S)-N=carbamoyl-a-methylleucine 1.10! 7 was obtained as white crystals [[α')25=+8.0° (cm0.5
゜O,IN-NaOH)). Thus obtained (S)
-N-carbamoyl-α-methylleucine 1.001 was added to 25 ml of 2N-HC1 solution and cyclized by heating at 80°C for 2 hours, (S)-4-methyl-4-isobutylimidazolidine-2,5- Dione 0.851 was obtained as white crystals.
(α) 25 =o、 so(c = 0.5 、0.
I N−Na0H)mp、 131〜134°C
実施例6
実施例5と同様に調製した栄養液体培地に、予めブイヨ
ン寒天スラントで30°C124時間培養したノカルデ
イア・コラリナ(Nocardiacorallina
) I FO3358を一白金耳接種して30°Cで2
4時間振とう下に培養を行なった。(α) 25 = o, so (c = 0.5, 0.
I N-Na0H) mp, 131-134°C Example 6 Nocardia corallina, which had been previously cultured on a bouillon agar slant at 30°C for 124 hours, was added to a nutrient liquid medium prepared in the same manner as in Example 5.
) Inoculated with one loopful of I FO3358 and incubated at 30°C for 2 hours.
Culture was performed under shaking for 4 hours.
この培養液の200m/を用い、遠心分離して得た生菌
体を更に同量の09%食塩水で洗浄したのち、再び遠心
分離して集菌し下記反応液成分として使用した。Using 200 m/ml of this culture solution, the viable cells obtained by centrifugation were further washed with the same amount of 09% saline, and then centrifuged again to collect the bacteria and used as a component of the reaction solution described below.
反応液組成:
(1) (几5)−N−カルバモイル−α−メチルフ
ェニルグリシン240gをナトリウム塩として溶解させ
(pH7,2)、液量40yttlに調整した基質溶液
(2) 前記生菌体を09%食塩水を用い懸濁し、液
量40 mlに調整した菌体懸濁液
と記(1)、(2)を混合して200m1容四ツ目丸底
フラスコに入れ、撹拌しなから37“Cにて20時間反
応させた。この反応中、0.5 N−HG!1溶液を用
い反応系のpHを7.2に継続的に保持した。反応後、
反応液を冷却しpHを乙0に調整した後、遠心分離によ
り反応中に析出した結晶と菌体の不溶混合物と上澄液と
に分離した。この遠心分離して得た不溶物に水200肩
/を加え、10 N−NaOH溶液によりpHを11.
5に調整し、1時間撹拌して混在結晶を溶解させた後、
再び遠心分離して菌体を除去した。次いで6N−HOI
溶液を用い、この上澄液のpHを乙0に再調整すると白
色沈澱が析出した。この沈澱を戸数し、エタノールより
再結晶して@)−4−メチル−4−フェニルイミダゾリ
ジン−2,5−ジオンの白色結晶1.031i’を得た
。Reaction solution composition: (1) Substrate solution in which 240 g of (几5)-N-carbamoyl-α-methylphenylglycine was dissolved as a sodium salt (pH 7.2) and the liquid volume was adjusted to 40 yttl. Mix (1) and (2) with the bacterial cell suspension suspended in 0.09% saline and adjusted to a volume of 40 ml, put into a 200 ml four-eye round bottom flask, and stir without stirring. The reaction was carried out for 20 hours at "C". During this reaction, the pH of the reaction system was continuously maintained at 7.2 using a 0.5 N-HG!1 solution. After the reaction,
After cooling the reaction solution and adjusting the pH to 0, it was separated by centrifugation into an insoluble mixture of crystals precipitated during the reaction and bacterial cells, and a supernatant. 200ml of water was added to the insoluble matter obtained by centrifugation, and the pH was adjusted to 11.0 with a 10 N-NaOH solution.
5 and stirred for 1 hour to dissolve mixed crystals,
The cells were removed by centrifugation again. Then 6N-HOI
When the pH of this supernatant liquid was readjusted to 0 using the solution, a white precipitate was deposited. This precipitate was separated and recrystallized from ethanol to obtain 1.031i' of white crystals of -4-methyl-4-phenylimidazolidine-2,5-dione.
NM几 899m (DMS 0−de) : 1.7
(3H。NM 几 899m (DMS 0-de): 1.7
(3H.
s、a−C!H3)、7.3〜7.6 (5H,m、
aromatic)、8、611H,S、 NH)、1
0.8 (IH,s、 NH)IRcm (KBr−
disk) : 3280゜3210.1765.17
10.1495゜1440.1400.13G5,12
50゜(ff)25=−14to(c = 0.5 、
0. I N−Na0H)mp、 240〜242’
C
一方、前記菌体反応後の遠心分離上澄液のpHを、8N
−HC!l溶液を用い1.0に調整すると白色。s,a-C! H3), 7.3-7.6 (5H, m,
aromatic), 8, 611H,S, NH), 1
0.8 (IH,s, NH)IRcm (KBr-
disk): 3280°3210.1765.17
10.1495°1440.1400.13G5,12
50°(ff)25=-14to(c=0.5,
0. I N-NaOH) mp, 240-242'
C On the other hand, the pH of the centrifuged supernatant after the bacterial cell reaction was adjusted to 8N.
-HC! White when adjusted to 1.0 using l solution.
沈澱が析出した。この沈澱を戸数し充分水洗した後、減
圧下に乾燥して(S) −N−カルバモイル−α−メチ
ルフェニルグリシンt 0711を得た〔〔α〕25;
+52°(cm 0.5 、0. I N−NaOH)
)。こうして得た(S) −N−カルバモイル−α−
メチルフェニルグリシン0.80Fを2N−H2SO4
溶液2゜罰に懸濁し、80°Cにて撹拌下に3.5時間
加熱環化反応した。冷却後、析出した結晶を戸数し、エ
タノールより再結晶して(S) −4−メチル−4−フ
ェニルイミダゾリジン−2,5−ジオン0.68gを得
た。A precipitate was deposited. This precipitate was washed thoroughly with water and then dried under reduced pressure to obtain (S) -N-carbamoyl-α-methylphenylglycine t0711 [[α]25;
+52° (cm 0.5, 0.IN-NaOH)
). (S)-N-carbamoyl-α- thus obtained
Methylphenylglycine 0.80F 2N-H2SO4
The solution was suspended at a temperature of 2° and heated for 3.5 hours at 80°C for cyclization reaction with stirring. After cooling, the precipitated crystals were collected and recrystallized from ethanol to obtain 0.68 g of (S)-4-methyl-4-phenylimidazolidine-2,5-dione.
(/2’l 譬=+139.5°(cm0.5 、0.
I N −NaOH)mp、 240〜242°C
実施例7
(几5)−4−カルバモイルアミノ−6−フルオロクロ
マン−
の4−カルバモイルアミノ−6−フルオロ−2−メチル
クロマン−4−カルボン酸((2S,4R)と(2几,
4S)の混合物〕を反応基質として使用して、実施例2
と同°様の操作を行ない、酢酸エチル抽出液より(28
,4R)−6−フルオロ−2−メチル−スピロ−(クロ
マン−4,4′−イミダゾリジン) − 2: s’−
ジオンの白色結晶049gを得た( (12)”ニー2
2 4°(cm1. 0 、 EtOH )、mp。(/2'l parable = +139.5° (cm0.5, 0.
I N -NaOH)mp, 240-242°C Example 7 4-Carbamoylamino-6-fluoro-2-methylchroman-4-carboxylic acid ((几5) (2S, 4R) and (2 liters,
4S)] as the reaction substrate, Example 2
Perform the same operation as above, and use the ethyl acetate extract (28
,4R)-6-fluoro-2-methyl-spiro-(chroman-4,4'-imidazolidine)-2: s'-
Obtained 049g of white crystals of dione ((12)" knee 2
24° (cm1.0, EtOH), mp.
250〜252°C))。また、菌体反応液の遠心分離
上澄液より得た白色沈澱を実施例3と同様に処理して、
(2L 48)−N−カルバモイルアミノ−6−フルオ
ロ−2−メチルクロマン−4−カルボン酸を加熱環化し
て、(2R,48)−6−フルオロ−2−メチル−スピ
ロ−〔クロマン− 4. 4’ーイミダゾリジン) −
q: 5’−ジオンの白色結晶0、45fを得た〔〔
α)”=+2 2 5°(cm1.0。250-252°C)). In addition, the white precipitate obtained from the centrifuged supernatant of the bacterial cell reaction solution was treated in the same manner as in Example 3.
(2L 48)-N-carbamoylamino-6-fluoro-2-methylchroman-4-carboxylic acid was heated and cyclized to form (2R,48)-6-fluoro-2-methyl-spiro-[chroman-4. 4'-imidazolidine) -
q: 0,45f white crystals of 5'-dione were obtained [[
α)”=+2 2 5° (cm1.0.
EtOH ) 、 mp. 250 〜25
2 °C 〕。EtOH), mp. 250 ~25
2 °C].
参考例1
実施例4で得た(S) −N−カルバモイル−α−メチ
ル−3.4−メチレンジオキシフェニルアラニン5、0
g、結晶水酸化バリウム25fおよび水125yptl
を混合し60時間煮沸還流した。反応終了後、更に水1
25罰を加え希硫酸でpI−It8に中和した。生成し
た硫酸バリウムの沈澱をP別し、P液を熱時脱色炭で脱
色して減圧濃縮した。残渣に20%塩酸80罰およびフ
ェノール4gを加え撹拌下に19時間還流した。反応後
、反応液より油状物を分取して除き減圧下に過剰の塩酸
を留去した。得られた残渣に水10m1を加え加熱溶解
して脱色炭による脱色処理を行なった後、少量の重亜硫
酸ソーダを含む5N−アンモニア水にてpH60に調整
し冷蔵庫に一夜放置した。析出した結晶を戸数し少量の
冷水で洗浄した後、乾燥することにより(S)−α−メ
チル−3,4−ジヒドロキシフェニルアラニン・3/2
水和物3.2yを得た。Reference Example 1 (S)-N-carbamoyl-α-methyl-3,4-methylenedioxyphenylalanine obtained in Example 4 5,0
g, crystalline barium hydroxide 25f and water 125yptl
were mixed and boiled under reflux for 60 hours. After the reaction is complete, add 1 more water
25 and neutralized to pI-It8 with dilute sulfuric acid. The resulting barium sulfate precipitate was separated from P, and the P solution was decolorized with hot decolorizing charcoal and concentrated under reduced pressure. 80% 20% hydrochloric acid and 4 g of phenol were added to the residue, and the mixture was refluxed for 19 hours with stirring. After the reaction, an oily substance was separated and removed from the reaction solution, and excess hydrochloric acid was distilled off under reduced pressure. After adding 10 ml of water to the obtained residue and dissolving it under heating, and decolorizing with decolorizing charcoal, the pH was adjusted to 60 with 5N ammonia water containing a small amount of sodium bisulfite, and the mixture was left in a refrigerator overnight. After washing the precipitated crystals with a small amount of cold water and drying them, (S)-α-methyl-3,4-dihydroxyphenylalanine 3/2
3.2y of hydrate was obtained.
〔α〕25−−55°(C=2.0. N−HGI!l
)mp、 306〜307°C(分解)〔効果〕
本発明が、最近糖尿病の特定の慢性症状(白内障、神経
疾患など)の予防あるいは治療薬として注目されている
光学活性ヒダントイン、(S)−6−フルオロ−スピロ
−〔クロマン−4,4′−イミダゾリジン) −2s’
−ジオン(USAN;ツルビニル(5orbinil
) )や、抗高血圧剤として広く用いられている光学活
性α−アミノ酸(S)−α−メチル−3,4−ジヒドロ
キシフェニルアラニン(L−メチルドーパ)などの合成
に、効率的な光学分割手段として有利に適用できること
を考えると、安価な微生物などの酵素を用いる本発明は
、極めて実用性に富むこれら光学活性化合物の有効な製
造法を提供するものであるといえる。さらに本発明は、
従来予想もされていなかったα−炭素とに水素原子ヲ持
たないN−カルバモイル−α−アミノ酸が酵素的な環化
反応を受けてヒダントイン類に生化学的に変換しうると
いう全(新しい知見を提供するものである。[α]25--55° (C=2.0.N-HGI!l
) mp, 306-307°C (decomposition) [Effect] The present invention is directed to optically active hydantoin, (S)-, which has recently attracted attention as a preventive or therapeutic agent for specific chronic symptoms of diabetes (cataracts, neurological diseases, etc.). 6-fluoro-spiro-[chroman-4,4'-imidazolidine)-2s'
-dione (USAN; 5orbinil
)) and the optically active α-amino acid (S)-α-methyl-3,4-dihydroxyphenylalanine (L-methyldopa), which is widely used as an antihypertensive agent. Considering that the present invention can be applied to enzymes such as inexpensive microorganisms, it can be said that the present invention provides an extremely practical and effective method for producing these optically active compounds. Furthermore, the present invention
This new finding shows that N-carbamoyl-α-amino acids, which do not have a hydrogen atom on the α-carbon, can be biochemically converted into hydantoins through an enzymatic cyclization reaction, which was previously unanticipated. This is what we provide.
Claims (3)
ル基、アラルキル基、アリール基またはそれらの置換体
であり、あるいはR^1とR^2とが一つの非対照な環
状化合物を形成する。〕で示されるN−カルバモイル−
α−アミノ酸のラセミ体に一方の立体配置のみを対応す
る一般式(II) ▲数式、化学式、表等があります▼(II) 〔式中、R^1とR^2は前記( I )と同じ。*は不
斉炭素を表わす。〕 で示されるヒダントインに変換する能力を有するアエロ
バクター属、アグロバクテリウム属、バシルス属、コリ
ネバクテリウム属またはノカルデイア属に属する微生物
の酵素を作用させ一般式(II)で示される光学活性ヒダ
ントインに変換し、未反応の光学活性なN−カルバモイ
ル−α−アミノ酸を生成したヒダントインと分離した後
、該光学活性なN−カルバモイル−α−アミノ酸を酸性
下加熱環化して対応する光学活性なヒダントインを生成
せしめることを特徴とする光学活性ヒダントイン類の製
造方法。(1) General formula (I) ▲Mathematical formulas, chemical formulas, tables, etc.▼(I) [In the formula, R^1 and R^2 are each independently different alkyl groups, aralkyl groups, aryl groups, or substituents thereof. or R^1 and R^2 form one asymmetric cyclic compound. ]N-carbamoyl-
General formula (II) that corresponds to only one configuration in the racemic form of α-amino acid ▲There are mathematical formulas, chemical formulas, tables, etc.▼ (II) [In the formula, R^1 and R^2 are the same as the above (I) same. * represents an asymmetric carbon. ] The enzyme of a microorganism belonging to the genus Aerobacter, Agrobacterium, Bacillus, Corynebacterium or Nocardia which has the ability to convert into the hydantoin represented by the general formula (II) is reacted with the enzyme to convert the optically active hydantoin represented by the general formula (II). After converting and separating unreacted optically active N-carbamoyl-α-amino acid from the generated hydantoin, the optically active N-carbamoyl-α-amino acid is heated and cyclized under acidic conditions to produce the corresponding optically active hydantoin. 1. A method for producing optically active hydantoins, which comprises producing optically active hydantoins.
ル基を表わす。〕で表わされる4−カルバモイルアミノ
クロマン−4−カルボン酸類を使用する特許請求の範囲
第1項記載の製造方法。(2) R^1 and R^2 are ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [X represents a halogen atom, and Ra and Rb each represent a hydrogen atom or a methyl group. The manufacturing method according to claim 1, which uses 4-carbamoylaminochroman-4-carboxylic acids represented by the following.
( I )式の不斉炭素に関して(S)体である特許請求
の範囲第1項もしくは第2項記載の製造方法。(3) Optically active N-carbamoyl-α-amino acid,
The manufacturing method according to claim 1 or 2, wherein the asymmetric carbon of formula (I) is in the (S) form.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23025788A JPH01124398A (en) | 1988-09-14 | 1988-09-14 | Production of optically active hydantoins |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23025788A JPH01124398A (en) | 1988-09-14 | 1988-09-14 | Production of optically active hydantoins |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59195392A Division JPS6172762A (en) | 1984-09-17 | 1984-09-17 | Preparation of optically active hydantoin |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01124398A true JPH01124398A (en) | 1989-05-17 |
JPH0555117B2 JPH0555117B2 (en) | 1993-08-16 |
Family
ID=16904969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP23025788A Granted JPH01124398A (en) | 1988-09-14 | 1988-09-14 | Production of optically active hydantoins |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01124398A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2287152A2 (en) | 2002-06-05 | 2011-02-23 | Kaneka Corporation | Process for producing optically active alpha-methylcysteine derivative |
-
1988
- 1988-09-14 JP JP23025788A patent/JPH01124398A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2287152A2 (en) | 2002-06-05 | 2011-02-23 | Kaneka Corporation | Process for producing optically active alpha-methylcysteine derivative |
Also Published As
Publication number | Publication date |
---|---|
JPH0555117B2 (en) | 1993-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Vogel et al. | Glutamic γ-semialdehyde and Δ1-pyrroline-5-carboxylic acid, intermediates in the biosynthesis of proline1, 2 | |
JP2676568B2 (en) | Method for producing R (-)-mandelic acid and its derivatives | |
US5981239A (en) | Synthesis of optically active phenylalanine analogs using Rhodotorula graminis | |
JPS6172762A (en) | Preparation of optically active hydantoin | |
JPS6230758B2 (en) | ||
JPWO2003106689A1 (en) | Process for producing optically active α-methylcysteine derivative | |
JPS63276498A (en) | One stage enzymatic conversion of cephalosporine c and derivative to 7-aminocephalospranic acid and derivative | |
JPH01124398A (en) | Production of optically active hydantoins | |
JPS61242589A (en) | Production of l-sulfur-containing amino acid | |
RU2205220C2 (en) | METHOD OF SYNTHESIS OF α-HYDROXYACIDS USING NOVEL MICROORGANISM AND NOVEL MICROORGANISM | |
JPH0928390A (en) | Microbiological production of glycolic acid | |
WO2002008439A1 (en) | Process for the preparation of 2-amino acids | |
JPS6225990A (en) | Production of d-alpha-amino acid | |
JPH03277292A (en) | Production of optically active 2-hydroxycarboxylic acid | |
JPH02222692A (en) | Production of sulfur-containing l-amino acid | |
JPH1042886A (en) | Production of beta-alanine by microorganism | |
JPS58187198A (en) | Preparation of s-carboxymethyl-l-cysteine | |
JPS5816692A (en) | Preparation of l-tryptophan by enzyme | |
JPS6371196A (en) | Production of d-n-carbamyl-alpha-amino acid | |
JPH06261787A (en) | Production of optically active beta-amino acid | |
JPH03117493A (en) | Production of optically active amino acids | |
JPH0254077B2 (en) | ||
JP2716477B2 (en) | Method for producing S-carboxymethyl-L-cysteine | |
JPH0542427B2 (en) | ||
JPH0611232B2 (en) | Method for producing L-sulfur-containing amino acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |